5-hydroxytryptamine receptor 2A ; Homo sapiens

12 Article(s)
Pub. Year
#Total Relationships
1 29785111 Association of serotonin receptor 2a haplotypes with obsessive-compulsive disorder and its treatment response in Iranian patients: a genetic and pharmacogenetic study. 2018 1
2 18817806 Intracerebroventricular fluvoxamine administration inhibited pain behavior but increased Fos expression in affective pain pathways. 2009 Jan 2
3 16205777 Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients. 2006 Apr 1
4 16360124 Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors. 2006 Jan 5 1
5 16874005 Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients. 2006 1
6 12607287 [Serotonin 2A receptor gene polymorphism and clinical efficacy of fluvoxamine in children with autistic disorder]. 2003 Jan 1
7 12755054 [Studies on the adverse effects of fluvoxamine treatment in children with autistic disorder: correlation with genetic polymorphism in serotonin related genes]. 2003 May 1
8 12886034 Monoamine oxidase A gene polymorphism, 5-HT 2A receptor gene polymorphism and incidence of nausea induced by fluvoxamine. 2003 1
9 12057029 Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. 2002 Mar 1
10 12422060 Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder. 2002 1
11 9241009 The effect of fluvoxamine on serum prolactin and serum sodium concentrations: relation to platelet 5-HT2A receptor status. 1997 Aug 1
12 9335078 Effect of fluvoxamine on platelet 5-HT2A receptors as studied by [3H]lysergic acid diethylamide ([3H]LSD) binding in healthy volunteers. 1997 Sep 2